tiprankstipranks
CytoDyn (CYDY)
OTHER OTC:CYDY

CytoDyn (CYDY) Stock Price & Analysis

630 Followers

CYDY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.13 - $0.42
Previous Close$0.14
Volume1.18M
Average Volume (3M)2.58M
Market Cap
$150.84M
Enterprise Value$179.79M
Total Cash (Recent Filing)$1.40M
Total Debt (Recent Filing)$30.34M
Price to Earnings (P/E)
Beta0.83
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding993,366,000
10 Day Avg. Volume3,296,721
30 Day Avg. Volume2,578,372
Standard Deviation0.49
R-Squared0.00049
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)-1.16
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-14.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-8.71
Enterprise Value/Ebitda-88.30
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

7.55%0.02%<0.01%92.42%
7.55%
Insiders
<0.01% Other Institutional Investors
92.42% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

CYDY FAQ

What was CytoDyn’s price range in the past 12 months?
CytoDyn lowest stock price was $0.13 and its highest was $0.42 in the past 12 months.
    What is CytoDyn’s market cap?
    Currently, no data Available
    When is CytoDyn’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were CytoDyn’s earnings last quarter?
    Currently, no data Available
    Is CytoDyn overvalued?
    According to Wall Street analysts CytoDyn’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does CytoDyn pay dividends?
      CytoDyn does not currently pay dividends.
      What is CytoDyn’s EPS estimate?
      CytoDyn’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does CytoDyn have?
      CytoDyn has 1,058,560,500 shares outstanding.
        What happened to CytoDyn’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of CytoDyn?
        Currently, no hedge funds are holding shares in CYDY
        ---

        CytoDyn Stock Smart Score

        10
        Unlock Smart Score
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Company Description

        CytoDyn

        CytoDyn, Inc. is a clinical-stage biotechnology company, which engages in the development of innovative treatments for multiple therapeutic indications based on leronlimab. Its product include HIV, cancer, graft-versus-host disease (GVHD), and PCa test. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        G1 Therapeutics
        Bioxcel Therapeutics
        Blueprint Medicines
        Fate Therapeutics
        Popular Stocks
        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis